StocktoriaGalmed Pharmaceuticals Ltd. GLMD
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Net income | -$10.3M | -$7.5M | -$6.9M | -$17.9M | -$32.5M |
| Operating cash flow | -$6.3M | -$5.9M | -$6.1M | -$18.5M | -$32.9M |
| Free cash flow | — | — | — | -$18.5M | -$32.9M |
| Total assets | $18.6M | $18.5M | $16.6M | $16.6M | $36.6M |
| Shareholders' equity | $15.8M | $16.3M | $13.9M | $13.4M | $30.5M |
| Ratios | |||||
| Return on assets | -55.3% | -40.6% | -41.6% | -107.9% | -88.7% |
| Return on equity | -65.3% | -46.0% | -49.8% | -133.1% | -106.5% |
| Current ratio | 6.55 | 7.42 | 4.81 | 4.76 | 6.13 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001595353 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.